List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 4166 studies with search of:   United States, Tennessee
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Cerebrovascular Accident
Interventions: Drug: Dabigatran etexilate;   Drug: Warfarin
2 Completed Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
3 Recruiting Assessment and Tracking of Long-Term Alefacept Safety
Condition: Psoriasis
Intervention: Drug: Alefacept exposure
4 Recruiting Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer
Condition: Colorectal Neoplasms
Interventions: Drug: bevacizumab;   Drug: AG-013726;   Drug: AG-013736 (axitinib)
5 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Condition: Lung Cancer
Interventions: Drug: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: paclitaxel;   Drug: vinorelbine ditartrate
6 Recruiting A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Condition: Atopic Dermatitis
Intervention:
7 Active, not recruiting Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
Condition: Breast Cancer
Interventions: Drug: raloxifene;   Drug: tamoxifen citrate
8 Recruiting A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)
Conditions: Colorectal Cancer;   Non-Small Cell Lung Cancer
Intervention:
9 Active, not recruiting A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab;   Drug: placebo;   Drug: erlotinib HCl
10 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Drug: placebo
11 Recruiting RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial
Conditions: Heart Failure;   Anemia;   Cardiovascular Disease;   Ventricular Dysfunction;   Congestive Heart Failure
Interventions: Drug: Darbepoetin alfa;   Drug: Placebo
12 Completed Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Albiglutide (GSK716155) or exenatide
13 Active, not recruiting Letrozole and Erlotinib in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Locally Recurrent or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: erlotinib hydrochloride;   Drug: letrozole;   Procedure: fluorescence in situ hybridization;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis
14 Recruiting A Study of RO4607381 in Stable Coronary Heart Disease Patients With Recent Acute Coronary Syndrome
Condition: Coronary Heart Disease
Interventions: Drug: RO4607381;   Drug: Placebo;   Drug: Evidence-based medical care for Acute Coronary Syndrome
15 Active, not recruiting A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer
Condition: Lung Neoplasms
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: SU011248
16 Recruiting Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid;   Osteoarthritis
Interventions: Drug: celecoxib;   Drug: Ibuprofen;   Drug: Naproxen
17 Recruiting Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
Condition: Multiple Myeloma
Interventions: Drug: bortezomib, thalidomide, and dexamethasone (VTD);   Drug: bortezomib and dexamethasone (VD);   Drug: bortezomib, melphalan and prednisone (VMP)
18 Recruiting A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis.
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab;   Drug: Placebo;   Drug: Permitted DMARDs
19 Completed TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: TLK286 HCl for injection;   Drug: topotecan hydrochloride for injection;   Drug: doxorubicin HCl liposome injection
20 Recruiting Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services